AI Proteins Partners with Bristol Myers Squibb to Develop Miniprotein-Based Therapeutics
CompanyDeals

AI Proteins Partners with Bristol-Myers Squibb to Develop Miniprotein-Based Therapeutics

Novatim Immune Therapeutics' Y-0301 Receives FDA Clearance for Clinical Trials
CompanyDrug

Novatim Immune Therapeutics’ Y-0301 Receives FDA Clearance for Clinical Trials

NMPA Releases 85th Batch of Reference Drugs for Generic Quality Consistency Evaluation
Policy / Regulatory

NMPA Releases 85th Batch of Reference Drugs for Generic Quality Consistency Evaluation

Hangzhou-Based HighField Biopharmaceutical Advances HF50 for HER-2 Tumors with NMPA Approval
CompanyDrug

HighField Biopharmaceutical’s HF50 Receives Tacit Clinical Approval from NMPA for HER-2 Positive Tumors

Shenyang Hongqi Pharma Secures NMPA Approval for Pretomanid in TB Treatment
CompanyDrug

Shenyang Hongqi Pharma Secures NMPA Approval for Pretomanid in TB Treatment

Chongqing Zhifei Biological and GlaxoSmithKline Amend Distribution Agreement for Herpes Vaccine
CompanyDeals

Chongqing Zhifei Biological and GlaxoSmithKline Amend Distribution Agreement for Herpes Vaccine

GSK plc Partners with Muna Therapeutics to Discover Alzheimer’s Disease Treatment Targets
CompanyDeals

GSK plc Partners with Muna Therapeutics to Discover Alzheimer’s Disease Treatment Targets

Jiangsu Hengrui's SHR-A2102 Earns Breakthrough Therapy Designation for Urothelial Carcinoma
CompanyDrug

Jiangsu Hengrui’s SHR-A2102 Earns Breakthrough Therapy Designation for Urothelial Carcinoma

Roche's Columvi Supplemental sBLA Accepted by FDA for Relapsed DLBCL Treatment
CompanyDrug

Roche’s Columvi Supplemental sBLA Accepted by FDA for Relapsed DLBCL Treatment

Teva Pharmaceutical to Divest Holdings in Teva Takeda Pharma to JKI
CompanyDrug

Teva Pharmaceutical to Divest Holdings in Teva Takeda Pharma to JKI

Eyebright Medical Technology Aims to Raise RMB 300 Million for Contact Lens Production Expansion
CompanyDeals

Eyebright Medical Technology Aims to Raise RMB 300 Million for Contact Lens Production Expansion

Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators
CompanyDeals

Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators